Mitochondrial dysfunction in inherited renal disease and acute kidney injury

Nature Reviews Nephrology

Volumn 12, Issue 5, 2016, Pages 267-280

  Emma, Francesco ^a   Montini, Giovanni ^b   Parikh, Samir M ^c   Salviati, Leonardo ^d  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE; PRENYL DIPHOSPHATE SYNTHASE, SUBUNIT 2, HUMAN; TRANSFERASE; UBIDECARENONE; UBIQUINONE;

ACUTE KIDNEY FAILURE; BIOSYNTHESIS; COENZYME Q10 DEFICIENCY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FOCAL GLOMERULOSCLEROSIS; GENE MUTATION; GLOMERULOPATHY; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; LEBER HEREDITARY OPTIC NEUROPATHY; MITOCHONDRIAL BIOGENESIS; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL GENE; MITOCHONDRIAL GENETICS; MITOPHAGY; MUSCLE BIOPSY; NEUROIMAGING; NEXT GENERATION SEQUENCING; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; RESPIRATORY CHAIN; REVIEW; ANALOGS AND DERIVATIVES; ANIMAL; DEFICIENCY; GENETICS; KEARNS SAYRE SYNDROME; METABOLISM; MITOCHONDRIAL MYOPATHY; MITOCHONDRION; MUTATION; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACUTE KIDNEY INJURY; ALKYL AND ARYL TRANSFERASES; ANIMALS; DNA, MITOCHONDRIAL; HUMANS; KEARNS-SAYRE SYNDROME; KIDNEY DISEASES; MITOCHONDRIA; MITOCHONDRIAL MYOPATHIES; MUTATION; OXIDATIVE PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; UBIQUINONE;

EID: 84955271606     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2015.214     Document Type: Review

References (160)

1. Andersson S. G., et al. The genome sequence of Rickettsia prowazekii and the origin of mitochondria. Nature 396, 133-140 (1998
2. Frey, T. G., & Mannella, C. A. The internal structure of mitochondria. Trends Biochem. Sci. 25, 319-324 (2000
3. Anderson S., et al. Sequence and organization of the human mitochondrial genome. Nature 290, 457-465 (1981
4. Schon, E. A., DiMauro, S., & Hirano, M. Human mitochondrial DNA: roles of inherited and somatic mutations. Nat. Rev. Genet. 13, 878-890 (2012
5. Opalinska, M., & Meisinger, C. Metabolic control via the mitochondrial protein import machinery. Curr. Opin. Cell Biol. 33, 42-48 (2015
6. Dimmer, K S., & Scorrano, L. (De)constructing mitochondria: what for? Physiology (Bethesda) 21 233-241 2006
7. Scorrano L., et al. A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev. Cell 2, 55-67 (2002
8. Acin-Perez, R., Fernandez-Silva, P., Peleato, M. L., Perez-Martos, A., & Enriquez, J. A. Respiratory active mitochondrial supercomplexes. Mol. Cell 32, 529-539 (2008
9. Ghezzi, D., & Zeviani, M. Assembly factors of human mitochondrial respiratory chain complexes: physiology and pathophysiology. Adv. Exp. Med. Biol. 748, 65-106 (2012
10. DiMauro, S., Schon, E. A., Carelli, V., & Hirano, M. The clinical maze of mitochondrial neurology. Nat. Rev. Neurol. 9, 429-444 (2013
11. Doimo M., et al. Genetics of coenzyme q10 deficiency. Mol. Syndromol. 5, 156-162 (2014
12. Nguyen T. P., et al. Molecular characterization of the human COQ5 C methyltransferase in coenzyme Q10 biosynthesis. Biochim. Biophys. Acta 1841, 1628-1638 (2014
13. Allen, J. W. Cytochrome c biogenesis in mitochondria-systems III and V. FEBS J. 278, 4198-4216 (2011
14. DiMauro, S., & Schon, E. A. Mitochondrial disorders in the nervous system. Annu. Rev. Neurosci. 31, 91-123 (2008
15. Mayr J. A., et al. Spectrum of combined respiratory chain defects. J. Inherit. Metab. Dis. 38, 4198-4216 (2015
16. Gorman G. S., et al. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann. Neurol. 77, 753-759 (2015
17. Petruzzella V., et al. Deep sequencing unearths nuclear mitochondrial sequences under Leber?s hereditary optic neuropathy-Associated false heteroplasmic mitochondrial DNA variants. Hum. Mol. Genet. 21, 3753-3764 (2012
18. Giordano C., et al. Pathogenesis of the deafness-Associated A1555G mitochondrial DNA mutation. Biochem. Biophys. Res. Commun. 293, 521-529 (2002
19. Doimo M., et al. Effect of vanillic acid on COQ6 mutants identified in patients with coenzyme Q10 deficiency. Biochim. Biophys. Acta 1842, 1-6 (2014
20. Emma, F., Bertini, E., Salviati, L., & Montini, G. Renal involvement in mitochondrial cytopathies. Pediatr. Nephrol. 27, 539-550 (2012
21. Quinzii, C. M., et al. Reactive oxygen species, oxidative stress, and cell death correlate with level of CoQ10 deficiency. FASEB J. 24, 3733-3743 (2010
22. Morison I. M., et al. A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia. Nat. Genet. 40, 387-389 (2008
23. De Rocco D., et al. Mutations of cytochrome c identified in patients with thrombocytopenia THC4 affect both apoptosis and cellular bioenergetics. Biochim. Biophys. Acta 1842, 269-274 (2014
24. Desbats M. A., et al. Primary coenzyme Q10 deficiency presenting as fatal neonatal multiorgan failure. Eur. J. Hum. Genet. 23, 1254-1258 (2015
25. Emma, F., Montini, G., Salviati, L., & Dionisi-Vici, C. Renal mitochondrial cytopathies. Int. J. Nephrol. 2011, 609213 (2011
26. Bodemer C., et al. Hair and skin disorders as signs of mitochondrial disease. Pediatrics 103, 428-433 (1999
27. Niaudet, P., & Rotig, A. The kidney in mitochondrial cytopathies. Kidney Int. 51, 1000-1007 (1997
28. Deetjen, P. Measurement of metabolism during renal work. Int. J. Biochem. 12, 243-244 (1980
29. Thurau, K. Renal Na reabsorption and O2 uptake in dogs during hypoxia and hydrochlorothiazide infusion. Proc. Soc. Exp. Biol. Med. 106, 714-717 (1961
30. Ogier H., et al. de Toni-Fanconi-Debré syndrome with Leigh syndrome revealing severe muscle cytochrome c oxidase deficiency. J. Pediatr. 112, 734-739 (1988
31. Niaudet P., et al. Deletion of the mitochondrial DNA in a case of de Toni-Debré-Fanconi syndrome and Pearson syndrome. Pediatr. Nephrol. 8, 164-168 (1994
32. Rotig, A. Renal disease and mitochondrial genetics. J. Nephrol. 16, 286-292 (2003
33. Morris A. A., et al. Neonatal Fanconi syndrome due to deficiency of complex III of the respiratory chain. Pediatr. Nephrol. 9, 407-411 (1995
34. Au K. M., et al. Mitochondrial DNA deletion in a girl with Fanconi?s syndrome. Pediatr. Nephrol. 22, 136-140 (2007
35. Kuwertz-Broking E., et al. Renal Fanconi syndrome: first sign of partial respiratory chain complex IV deficiency. Pediatr. Nephrol. 14, 495-498 (2000
36. Mochizuki H., et al. Mitochondrial encephalomyopathies preceded by de Toni-Debré-Fanconi syndrome or focal segmental glomerulosclerosis. Clin. Nephrol. 46, 347-352 (1996
37. De Meirleir L., et al. Clinical and diagnostic characteristics of complex III deficiency due to mutations in the BCS1L gene. Am. J. Med. Genet. A 121A, 126-131 (2003
38. Liu H. M., et al. A novel 3670 base pair mitochondrial DNA deletion resulting in multi-systemic manifestations in a child. Pediatr. Neonatol. 53, 264-268 (2012
39. Tzoufi, M., et al. A rare case report of simultaneous presentation of myopathy, Addison?s disease, primary hypoparathyroidism, and Fanconi syndrome in a child diagnosed with Kearns-Sayre syndrome. Eur. J. Pediatr. 172, 557-561 (2013
40. Pitchon E. M., et al. Patient with Fanconi syndrome (FS) and retinitis pigmentosa (RP) caused by a deletion and duplication of mitochondrial DNA (mtDNA). Klin. Monbl Augenheilkd 224, 340-343 (2007
41. Mori, K., Narahara, K., Ninomiya, S., Goto, Y., & Nonaka, I. Renal and skin involvement in a patient with complete Kearns-Sayre syndrome. Am. J. Med. Genet. 38, 583-587 (1991
42. Topaloglu R., et al. Two new cases with Pearson syndrome and review of Hacettepe experience. Turk. J. Pediatr. 50, 572-576 (2008
43. O?Toole, J. F. Renal manifestations of genetic mitochondrial disease. Int. J. Nephrol. Renovasc. Dis. 7, 57-67 (2014
44. Duncan A. J., et al. A nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease. Am. J. Hum. Genet. 84, 558-566 (2009
45. Lee Y. S., et al. Mitochondrial tubulopathy: the many faces of mitochondrial disorders. Pediatr. Nephrol. 16, 710-712 (2001
46. Gilbert, R. D., & Emms, M. Pearson?s syndrome presenting with Fanconi syndrome. Ultrastruct. Pathol. 20, 473-475 (1996
47. Ezgu F., et al. Severe renal tubulopathy in a newborn due to BCS1L gene mutation: effects of different treatment modalities on the clinical course. Gene 528, 364-366 (2013
48. Gai, X., et al. Mutations in FBXL4, encoding a mitochondrial protein, cause early-onset mitochondrial encephalomyopathy. Am. J. Hum. Genet. 93, 482-495 (2013
49. Tucker E. J., et al. Next-generation sequencing in molecular diagnosis: NUBPL mutations highlight the challenges of variant detection and interpretation. Hum. Mutat. 33, 411-418 (2012
50. Matsutani H., et al. Partial deficiency of cytochrome c oxidase with isolated proximal renal tubular acidosis and hypercalciuria. Child Nephrol. Urol. 12, 221-224 (1992
51. Martin-Hernandez E., et al. Renal pathology in children with mitochondrial diseases. Pediatr. Nephrol. 20, 1299-1305 (2005
52. Emma F., et al. ?Bartter-like? phenotype in Kearns-Sayre syndrome. Pediatr. Nephrol. 21, 355-360 (2006
53. Goto Y., et al. Renal tubular involvement mimicking Bartter syndrome in a patient with Kearns-Sayre syndrome. J. Pediatr. 116, 904-910 (1990
54. Visapaa, I., et al. GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L. Am. J. Hum. Genet. 71, 863-876 (2002
55. Wilson, F H., et al. A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science 306 1190-1194 2004
56. Reilly, R. F., & Ellison, D. H. Mammalian distal tubule: physiology, pathophysiology, and molecular anatomy. Physiol. Rev. 80, 277-313 (2000
57. McCormick, J. A., & Ellison, D. H. Distal convoluted tubule. Compr. Physiol. 5, 45-98 (2015
58. Simon, D. B., et al. Gitelman?s variant of Bartter?s syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat. Genet. 12, 24-30 (1996
59. Soltoff, S. P. ATP and the regulation of renal cell function. Annu. Rev. Physiol. 48, 9-31 (1986
60. Klootwijk E. D., et al. Mistargeting of peroxisomal EHHADH and inherited renal Fanconi?s syndrome. N. Engl. J. Med. 370, 129-138 (2014
61. Jefferson, J. A., Alpers, C. E., & Shankland, S. J. Podocyte biology for the bedside. Am. J. Kidney Dis. 58, 835-845 (2011
62. Muller-Deile, J., & Schiffer, M. The podocyte power-plant disaster and its contribution to glomerulopathy. Front. Endocrinol. (Lausanne) 5, 209 (2014
63. Saleem, M. A. 100 ways to kill a podocyte. Nephrol. Dial. Transplant. http://dx.doi.org/10.1093/ndt/gfu363 (2015
64. Higgins, G. C., & Coughlan, M. T. Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy? Br. J. Pharmacol. 171, 1917-1942 (2014
65. Che, R., Yuan, Y., Huang, S., & Zhang, A. Mitochondrial dysfunction in the pathophysiology of renal diseases. Am. J. Physiol. Renal Physiol. 306, F367-F378 (2014
66. Kawakami T., et al. Deficient autophagy results in mitochondrial dysfunction and FSGS. J. Am. Soc. Nephrol. 26, 1040-1052 (2015
67. Montini, G., Malaventura, C., & Salviati, L. Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. N. Engl. J. Med. 358, 2849-2850 (2008
68. Heeringa S. F., et al. COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J. Clin. Invest. 121, 2013-2024 (2011
69. Ashraf S., et al. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. J. Clin. Invest. 123, 5179-5189 (2013
70. Gasser, D. L., et al. Focal segmental glomerulosclerosis is associated with a PDSS2 haplotype and, independently, with a decreased content of coenzyme Q10. Am. J. Physiol. Renal Physiol. 305, F1228-1238 (2013
71. Quinzii C., et al. A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency. Am. J. Hum. Genet. 78, 345-349 (2006
72. Lopez L. C., et al. Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. Am. J. Hum. Genet. 79, 1125-1129 (2006
73. Vasta, V., Merritt, J. L. 2nd, Saneto, R. P., & Hahn, S. H. Next-generation sequencing for mitochondrial diseases: a wide diagnostic spectrum. Pediatr. Int. 54, 585-601 (2012
74. Salviati L., et al. Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: a CoQ10 responsive condition. Neurology 65, 606-608 (2005
75. Diomedi-Camassei F., et al. COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement. J. Am. Soc. Nephrol. 18, 2773-2780 (2007
76. McCarthy H. J., et al. Simultaneous sequencing of 24 genes associated with steroid-resistant nephrotic syndrome. Clin. J. Am. Soc. Nephrol. 8, 637-648 (2013
77. Dinwiddie D. L., et al. Diagnosis of mitochondrial disorders by concomitant next-generation sequencing of the exome and mitochondrial genome. Genomics 102, 148-156 (2013
78. Scalais, E., et al. Early myoclonic epilepsy, hypertrophic cardiomyopathy and subsequently a nephrotic syndrome in a patient with CoQ10 deficiency caused by mutations in para-hydroxybenzoate-polyprenyl transferase (COQ2). Eur. J. Paediatr. Neurol. 17, 625-630 (2013
79. The Multiple-System Atrophy Research Collaboration. Mutations in COQ2 in familial and sporadic multiple-system atrophy. N. Engl. J. Med. 369 233-244 (2013
80. Rotig A., et al. Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet 356, 391-395 (2000
81. Rahman, S., Clarke, C. F., & Hirano, M. 176th ENMC International Workshop: diagnosis and treatment of coenzyme Q10 deficiency. Neuromuscul. Disord. 22, 76-86 (2012
82. Mollet, J., et al. Prenyldiphosphate synthase, subunit 1 (PDSS1) and OH benzoate polyprenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders. J. Clin. Invest. 117, 765-772 (2007
83. Peng M., et al. Primary coenzyme Q deficiency in Pdss2 mutant mice causes isolated renal disease. PLoS Genet. 4, e1000061 (2008
84. Saiki R., et al. Coenzyme Q10 supplementation rescues renal disease in Pdss2kd/kd mice with mutations in prenyl diphosphate synthase subunit 2. Am. J. Physiol. Renal Physiol. 295, F1535-F1544 (2008
85. Falk M. J., et al. Probucol ameliorates renal and metabolic sequelae of primary CoQ deficiency in Pdss2 mutant mice. EMBO Mol. Med. 3, 410-427 (2011
86. Lopez, L. C., et al. Treatment of CoQ10 deficient fibroblasts with ubiquinone, CoQ analogs, and vitamin C: time-And compound-dependent effects. PLoS ONE 5, e11897 (2010
87. Quinzii C. M., et al. Tissue-specific oxidative stress and loss of mitochondria in CoQ-deficient Pdss2 mutant mice. FASEB J. 27, 612-621 (2013
88. Freyer, C., et al. Rescue of primary ubiquinone deficiency due to a novel COQ7 defect using 2, 4 dihydroxybensoic acid. J. Med. Genet. 52, 779-783 (2015
89. Desbats, M. A., Lunardi, G., Doimo, M., Trevisson, E., & Salviati, L. Genetic bases and clinical manifestations of coenzyme Q10 (CoQ10) deficiency. J. Inherit. Metab. Dis. 38, 145-156 (2015
90. Korkmaz E., et al. ADCK4 associated glomerulopathy causes adolescence-onset FSGS. J. Am. Soc. Nephrol. http://dx.doi.org/10.1681/ASN.2014121240 (2015
91. Mollet, J., et al. CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures. Am. J. Hum. Genet. 82, 623-630 (2008
92. Lagier-Tourenne, C., et al. ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency. Am. J. Hum. Genet. 82, 661-672 (2008
93. Luna-Sanchez M., et al. The clinical heterogeneity of coenzyme Q10 deficiency results from genotypic differences in the Coq9 gene. EMBO Mol. Med. 7, 670-687 (2015
94. Pavlakis, S. G., Phillips, P. C., DiMauro, S., De Vivo, D. C., & Rowland, L. P. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann. Neurol. 16, 481-488 (1984
95. Mehrazin M., et al. Longitudinal changes of mtDNA A3243G mutation load and level of functioning in MELAS. Am. J. Med. Genet. A 149A, 584-587 (2009
96. Seidowsky A., et al. Renal involvement in MELAS syndrome-A series of 5 cases and review of the literature. Clin. Nephrol. 80, 456-463 (2013
97. Hall A. M., et al. The urinary proteome and metabonome differ from normal in adults with mitochondrial disease. Kidney Int. 87, 610-622 (2015
98. Wilichowski, E., Pouwels, P. J., Frahm, J., & Hanefeld, F. Quantitative proton magnetic resonance spectroscopy of cerebral metabolic disturbances in patients with MELAS. Neuropediatrics 30, 256-263 (1999
99. Salviati L., et al. Novel SURF1 mutation in a child with subacute encephalopathy and without the radiological features of Leigh syndrome. Am. J. Med. Genet. A 128A, 195-198 (2004
100. Suomalainen A., et al. FGF 21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Lancet Neurol. 10, 806-818 (2011
101. Gropman, A. L. Neuroimaging in mitochondrial disorders. Neurotherapeutics 10, 273-285 (2013
102. Bricout M., et al. Brain imaging in mitochondrial respiratory chain deficiency: combination of brain MRI features as a useful tool for genotype/phenotype correlations. J. Med. Genet. 51, 429-435 (2014
103. Leigh, P. N., Al Sarraj, S., & DiMauro, S. Subacute necrotising encephalomyelopathy (Leigh?s disease; Leigh syndrome). J. Neurol. Neurosurg. Psychiatry 86, 363-365 (2015
104. Sundaram C., et al. Contribution of muscle biopsy and genetics to the diagnosis of chronic progressive external opthalmoplegia of mitochondrial origin. J. Clin. Neurosci. 18, 535-538 (2011
105. Trevisson, E., DiMauro, S., Navas, P., & Salviati, L. Coenzyme Q deficiency in muscle. Curr. Opin. Neurol. 24, 449-456 (2011
106. Spinazzi, M., Casarin, A., Pertegato, V., Salviati, L., & Angelini, C. Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells. Nat. Protoc. 7, 1235-1246 (2012
107. Montero R., et al. Analysis of coenzyme Q10 in muscle and fibroblasts for the diagnosis of CoQ10 deficiency syndromes. Clin. Biochem. 41, 697-700 (2008
108. Payne, B. A., Gardner, K., Coxhead, J., & Chinnery, P. F. Deep resequencing of mitochondrial DNA. Methods Mol. Biol. 1264, 59-66 (2015
109. Shanske S., et al. Varying loads of the mitochondrial DNA A3243G mutation in different tissues: implications for diagnosis. Am. J. Med. Genet. A 130A, 134-137 (2004
110. Yubero D., et al. Molecular diagnosis of coenzyme Q10 deficiency. Expert Rev. Mol. Diagn. 15, 1049-1059 (2015
111. Sadowski C. E., et al. A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J. Am. Soc. Nephrol. 26, 1279-1289 (2015
112. Tran M., et al. PGC 1α promotes recovery after acute kidney injury during systemic inflammation in mice. J. Clin. Invest. 121, 4003-4014 (2011
113. Brooks, C., Wei, Q., Cho, S. G., & Dong, Z. Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J. Clin. Invest. 119, 1275-1285 (2009
114. Manny J., et al. Structural changes in the perfused canine kidney exposed to the direct action of endotoxin. Isr. J. Med. Sci. 16, 153-161 (1980
115. Trump B. F., et al. The application of electron microscopy and cellular biochemistry to the autopsy. Hum. Pathol. 6, 499-516 (1975
116. Takasu O., et al. Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. Am. J. Respir. Crit. Care Med. 187, 509-517 (2013
117. Parekh D. J., et al. Tolerance of the human kidney to isolated controlled ischemia. J. Am. Soc. Nephrol. 24, 506-517 (2013
118. Zsengeller Z. K., et al. Cisplatin nephrotoxicity involves mitochondrial injury with impaired tubular mitochondrial enzyme activity. J. Histochem. Cytochem. 60, 521-529 (2012
119. Funk, J. A., & Schnellmann, R. G. Persistent disruption of mitochondrial homeostasis after acute kidney injury. Am. J. Physiol. Renal Physiol. 302, F853-F864 (2012
120. Zhang Q., et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464, 104-107 (2010
121. Feldkamp, T., Kribben, A., Roeser, N. F., Senter, R. A., & Weinberg, J. M. Accumulation of nonesterified fatty acids causes the sustained energetic deficit in kidney proximal tubules after hypoxia-reoxygenation. Am. J. Physiol. Renal Physiol. 290, F465-F477 (2006
122. Weinberg, J. M., Venkatachalam, M. A., Roeser, N. F., & Nissim, I. Mitochondrial dysfunction during hypoxia/reoxygenation and its correction by anaerobic metabolism of citric acid cycle intermediates. Proc. Natl Acad. Sci. USA 97, 2826-2831 (2000
123. Bienholz A., et al. Substrate modulation of fatty acid effects on energization and respiration of kidney proximal tubules during hypoxia/reoxygenation. PLoS ONE 9, e94584 (2014
124. Li S., et al. Transgenic expression of proximal tubule peroxisome proliferator-Activated receptor-α in mice confers protection during acute kidney injury. Kidney Int. 76, 1049-1062 (2009
125. Tannenbaum, J., Purkerson, M. L., & Klahr, S. Effect of unilateral ureteral obstruction on metabolism of renal lipids in the rat. Am. J. Physiol. 245, F254-F262 (1983
126. Zager, R. A., Johnson, A. C., & Hanson, S. Y. Renal tubular triglyercide accumulation following endotoxic, toxic, and ischemic injury. Kidney Int. 67, 111-121 (2005
127. Cocheme H. M., et al. Mitochondrial targeting of quinones: therapeutic implications. Mitochondrion 7, S94-S102 (2007
128. Kelso G. F., et al. Selective targeting of a redox-Active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J. Biol. Chem. 276, 4588-4596 (2001
129. Zhao, K., et al. Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J. Biol. Chem. 279, 34682-34690 (2004
130. Szeto H. H., et al. Mitochondria-Targeted peptide accelerates ATP recovery and reduces ischemic kidney injury. J. Am. Soc. Nephrol. 22, 1041-1052 (2011
131. Mukhopadhyay P., et al. Mitochondrial-Targeted antioxidants represent a promising approach for prevention of cisplatin-induced nephropathy. Free Radic. Biol. Med. 52, 497-506 (2012
132. Tang, W. X., Wu, W. H., Qiu, H. Y., Bo, H., & Huang, S. M. Amelioration of rhabdomyolysis-induced renal mitochondrial injury and apoptosis through suppression of Drp 1 translocation. J. Nephrol. 26, 1073-1082 (2013
133. Morigi M., et al. Sirtuin 3 dependent mitochondrial dynamic improvements protect against acute kidney injury. J. Clin. Invest. 125, 715-726 (2015
134. Ishihara M., et al. Sestrin 2 and BNIP3 regulate autophagy and mitophagy in renal tubular cells in acute kidney injury. Am. J. Physiol. Renal Physiol. 305, F495-F509 (2013
135. Jiang M., et al. Autophagy in proximal tubules protects against acute kidney injury. Kidney Int. 82, 1271-1283 (2012
136. Puigserver, P., et al A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92 829-839 1998
137. Sweeney, T. E., Suliman, H. B., Hollingsworth, J. W., & Piantadosi, C. A. Differential regulation of the PGC family of genes in a mouse model of Staphylococcus aureus sepsis. PLoS ONE 5, e11606 (2010
138. Sweeney, T E., Suliman, H. B., Hollingsworth, J. W., Welty-Wolf, K. E., & Piantadosi, C. A. A toll-like receptor 2 pathway regulates the Ppargc1a/b metabolic co activators in mice with Staphylococcal aureus sepsis. PLoS ONE 6 e25249 2011
139. Rasbach, K. A., & Schnellmann, R. G. PGC 1α over-expression promotes recovery from mitochondrial dysfunction and cell injury. Biochem. Biophys. Res. Commun. 355, 734-739 (2007
140. Jesinkey S. R., et al. Formoterol restores mitochondrial and renal function after ischemia-reperfusion injury. J. Am. Soc. Nephrol. 25, 1157-1162 (2014
141. Wrigley, A., Wilkinson, S., & Appleby, J. B. Mitochondrial replacement: ethics and identity. Bioethics 29, 631-638 (2015
142. Schon, E A., et al. A direct repeat is a hotspot for large-scale deletion of human mitochondrial DNA. Science 244 346-349 1989
143. Glerum, D. M., & Tzagoloff, A. Isolation of a human cDNA for heme A: farnesyltransferase by functional complementation of a yeast cox10 mutant. Proc. Natl Acad. Sci. USA 91, 8452-8456 (1994
144. Lim, S. C., et al. Mutations in LYRM4, encoding iron-sulfur cluster biogenesis factor ISD11, cause deficiency of multiple respiratory chain complexes. Hum. Mol. Genet. 22, 4460-4473 (2013
145. Cogliati S., et al. Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency. Cell 155, 160-171 (2013
146. de Brito, O. M., & Scorrano, L. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 456, 605-610 (2008
147. Hirano, M., Lagier-Tourenne, C., Valentino, M. L., Marti, R., & Nishigaki, Y. Thymidine phosphorylase mutations cause instability of mitochondrial DNA. Gene 354, 152-156 (2005
148. Valnot I., et al. A mutation in the human heme A: farnesyltransferase gene (COX10) causes cytochrome c oxidase deficiency. Hum. Mol. Genet. 9, 1245-1249 (2000
149. Tay, S. K., et al. Unusual clinical presentations in four cases of Leigh disease, cytochrome C oxidase deficiency, and SURF1 gene mutations. J. Child Neurol. 20, 670-674 (2005
150. de Lonlay, P., et al. A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure. Nat. Genet. 29, 57-60 (2001
151. Tucker, E. J., et al. Mutations in the UQCC1 interacting protein, UQCC2, cause human complex III deficiency associated with perturbed cytochrome b protein expression. PLoS Genet. 9, e1004034 (2013
152. Magner M., et al. TMEM70 deficiency: long-Term outcome of 48 patients. J. Inherit. Metab. Dis. 38, 417-426 (2015
153. Saada A., et al. Antenatal mitochondrial disease caused by mitochondrial ribosomal protein (MRPS22) mutation. J. Med. Genet. 44, 784-786 (2007
154. Nakajima, J., et al. A novel homozygous YARS2 mutation causes severe myopathy, lactic acidosis, and sideroblastic anemia 2. J. Hum. Genet. 59, 229-232 (2014
155. Belostotsky, R., et al. Mutations in the mitochondrial seryl-TRNA synthetase cause hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis, HUPRA syndrome. Am. J. Hum. Genet. 88, 193-200 (2011
156. Bourdon, A., et al. Mutation of RRM2B, encoding p53 controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat. Genet. 39, 776-780 (2007
157. Prasad C., et al. Exome sequencing reveals a homozygous mutation in TWINKLE as the cause of multisystemic failure including renal tubulopathy in three siblings. Mol. Genet. Metab. 108, 190-194 (2013
158. El Hattab, A. W., & Scaglia, F. Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options. Neurotherapeutics 10, 186-198 (2013
159. Carrozzo, R., et al. SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness. Brain 130, 862-874 (2007
160. Dimmock D. P., et al. Clinical and molecular features of mitochondrial DNA depletion due to mutations in deoxyguanosine kinase. Hum. Mutat. 29, 330-331 (2008